The percutaneous nephrostomy catheter (PCNC) has evolved since its inception. Over more than half a century, it has gone from a temporary maneuver to a permanent fixture in a large proportion of patients who have incurable illnesses with obstructed renal drainage systems. Unfortunately, the research looking specifically at infectious complications associated with PCNCs suffers from oversimplification as studies predominantly assess sepsis alone. There are no standardized definitions or criteria to define the various infectious complications described in this paper. Although the PCNC has a relative paucity of infectious complications, which represents an excellent marker for patient care, the low rate of infection dictates a large sample size for sufficiently-powered research studies to be able to find a significant impact of interventional measures. In this review article, we discuss various aspects of pathogenesis and treatment of the different subtypes of PCNC-associated infections.
ChalmersN., JonesK., DrinkwaterK., UberoiR., TawnJ.The UK nephrostomy audit. Can a voluntary registry produce robust performance data? Clin Radiol.2008; 63(8): 888–894.
11.
HootonT.M., BradleyS.F., CardenasD.D.. Infectious Diseases Society of America. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis.2010; 50(5): 625–663.
SticklerD., YoungR., JonesG., SabbubaN., MorrisN.Why are Foley catheters so vulnerable to encrustation and blockage by crystalline bacterial biofilm?Urol Res.2003; 31(5): 306–311.
15.
EdwardsL.E., LockR., PowellC., JonesP.Post-catheterisation urethral strictures. A clinical and experimental study. Br J Urol.1983; 55(1): 53–56.
StammW.E.Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am J Med.1991; 91(3B): 65S–71S.
20.
TambyahP.A., HalvorsonK.T., MakiD.G.A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clin Proc.1999; 74(2): 131–136.
21.
CronanJ.J., MarcelloA., HornD.L., RobinsonA., DorfmanG.S., OpalS.Antibiotics and nephrostomy tube care: preliminary observations. Part I. Bacteriuria. Radiology.1989; 172(3 Pt 2): 1041–1042.
22.
GarciaM.M., GulatiS., LiepmannD., StackhouseG.B., GreeneK., StollerM.L.Traditional Foley drainage systems – do they drain the bladder?J Urol.2007; 177(1): 203–207.
23.
HinmanF.R.F.Yelovenous P back flow. J Am Med Assoc.1926; 87(16): 1287–1293.
24.
TroxelS.A., LowR.K.Renal intrapelvic pressure during percutaneous nephrolithotomy and its correlation with the development of postoperative fever. J Urol.2002; 168(4 Pt 1): 1348–1351.
25.
DaviesD.G., ParsekM.R., PearsonJ.P., IglewskiB.H., CostertonJ.W., GreenbergE.P.The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science.1998; 280(5361): 295–298.
SticklerD., MorrisN., MorenoM.C., SabbubaN.Studies on the formation of crystalline bacterial biofilms on urethral catheters. Eur J Clin Microbiol Infect Dis.1998; 17(9): 649–652.
28.
MariappanP., SmithG., BariolS.V., MoussaS.A., TolleyD.A.Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol.2005; 173(5): 1610–1614.
TambyahP.A., MakiD.G.The relationship between pyuria and infection in patients with indwelling urinary catheters: a prospective study of 761 patients. Arch Intern Med.2000; 160(5): 673–677.
43.
LangE.K.Renal, perirenal, and pararenal abscesses: percutaneous drainage. Radiology.1990; 174(1): 109–113.
44.
WolfJ.S.Jr., BennettC.J., DmochowskiR.R., HollenbeckB.K., PearleM.S., SchaefferA.J.Urologic Surgery Antimicrobial Prophylaxis Best Practice Policy Panel. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol.2008; 179(4): 1379–1390.
45.
NicolleL.E., BradleyS., ColganR., RiceJ.C., SchaefferA., HootonT.M.Infectious Diseases Society of America; American Society of Nephrology; American Geriatric Society. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis.2005; 40(5): 643–654.
VenkatesanA.M., KunduS., SacksD.. Society of Interventional Radiology Standards of Practice Committee. Practice guidelines for adult antibiotic prophylaxis during vascular and interventional radiology procedures. [corrected]. J Vasc Interv Radiol.2010; 21(11): 1611–1630, quiz 1631.
48.
SeyrekM., BinbayM., YurukE.. Perioperative Prophylaxis for Percutaneous Nephrolithotomy: Randomized Study Concerning the Drug and Dosage. J Endourol.2012 Aug 2. [Epub ahead of print]
49.
MariappanP., SmithG., MoussaS.A., TolleyD.A.One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. BJU Int.2006; 98(5): 1075–1079.
50.
DoǧanH.S., SahinA., CetinkayaY., AkdoǧanB., OzdenE., KendiS.Antibiotic prophylaxis in percutaneous nephrolithotomy: prospective study in 81 patients. J Endourol.2002; 16(9): 649–653.
51.
KumarS., BagS., GanesamoniR., MandalA.K., TanejaN., SinghS.K.Risk factors for urosepsis following percutaneous nephrolithotomy: role of 1 week of nitrofurantoin in reducing the risk of urosepsis. Urol Res.2012; 40(1): 79–86.
52.
BagS., KumarS., TanejaN., SharmaV., MandalA.K., SinghS.K.One week of nitrofurantoin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. Urology.2011; 77(1): 45–49.
53.
DarouicheR.O., GoetzL., KaldisT., Cerra-StewartC., AlSharifA., PriebeM.Impact of Stat Lock securing device on symptomatic catheter-related urinary tract infection: a prospective, randomized, multicenter clinical trial. Am J Infect Control.2006; 34(9): 555–560.
54.
SmithA.D.Smith's Textbook of Endourology: BC Decker; 2007.
